Dr Josep Sánchez de Toledo, responsible of the group of Translational Research in Child Cancer in the Vall d’Hebron Research Institute (VHIR) and responsible of the Oncology and Child Haematology Service was awarded with the Medalla Josep Trueta. This recognition is given by the Generalitat de Catalunya with the objective of honoring professionals or entities that have stood out for the services rendered in view of progress and improving health.Dr Sánchez de Toledo combines his clinical work in children with tumors and bone marrow transplants with the most advanced research in childhood cancer. To recognize his intensive activity for the children welfare and his leading research, his research group collects donations from important entities, patients associations and citizen’s initiatives, and obtains European and Catalan competitive aids, like La Marató de TV3. New memberships of the Real Academia MédicaBesides, two other researchers received also an important recognition for their work in health care and research. The "http://www.ramc.cat/" Reial Acadèmia de Medicina de Catalunya designated corresponding academician the Dr. Ricard Pujol, responsible of the Immunology research group in VHIR, and Dr Santiago Ramón y Cajal, responsible of the Oncology and Pathology Molecular research group.Dr Pujol, nowadays, is combining his work in VHIR with being the responsible of the Immunology Service of the Hospital and is a research adviser of the Institut Català de la Salut (ICS). In the field of the research, professor Pujol is an international leader in the study of the autoimmune diseases, especially in the Graves disease, and either in the identification of new biomarkers to diagnose these illnesses. Dr Ramón y Cajal also shares his dedication in VHIR with being the responsible of the pathological Anatomy Service in the Hospital. In the research field, he is a pioneer in the study of the signaling pathways in human tumors, the study of the aging gene expression in tumors and the identification of therapeutic targets associated with the tumor progress and the pharmacological resistance in colorectal carcinomas. A part from this recognition, Dr Ramón y Cajal has been recently chosen member of the Real Academia Nacional de Medicina.